Clinical Trial Update: Atropine and Spectacle Combination Treatment (ASPECT): 12-month Results of a Randomized Clinical Trial for Myopia Control [Phase 4]

View source ↗

Summary

12-month results from a Phase 4 randomized trial evaluating atropine combined with spectacles for myopia control (ASPECT). The update summarizes efficacy and sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Atropine (atropine)

Snippet

Sponsor: Hospital San Carlos, Madrid | Conditions: Myopia | Phase 4 | Status: ACTIVE_NOT_RECRUITING